… In a prospective, multicenter study, we tested 177 patients with measurable metastatic breast
cancer for levels of circulating tumor cells both before the patients were to start a new line …

… metastatic breast cancer had a prolonged survival compared with patients with recurrent
metastatic breast cancer … in survival of patients with de novo metastatic breast cancer compared …

… This current study highlights a growing appreciation that local regional treatment may,
indeed, have a greater influence on breast cancer survival than we have thought previously. …

… Thirty-five women with metastatic breast cancer received a battery of baseline psychological
tests; results were correlated with length of survival. Patients who died in less than one year …

… IV or “de novo” metastatic at presentation. In … I-III cancers will relapse with metastatic disease
at some future time [1–5]. While median overall survival (mOS) for metastatic breast cancer (…

… The addition of supportive–expressive group therapy to standard care for women with
metastatic breast cancer did not influence survival in our study. Women in the intervention group …

… in the survival of patients with metastatic breast cancer remains … metastatic breast cancer.
First, we review our current knowledge of metastatic breast cancer, including incidence, survival…

… In the current study, we have analyzed 439 women with metastatic breast cancer treated
at a single institution in order to identify potential prognostic factors associated with survival …

… therapy on survival in women with metastatic breast cancer. … therapy programme with
metastatic breast cancer patients. … support on survival in metastatic breast cancer. N Engl J Med …

… survival of patients with metastatic breast cancer (MBC) has been significantly prolonged over
the past decade due to improvement of anti-cancer … have long-term survival with treatment. …